Pathophysiology Of Transient Neonatal Pustular Melanosis: Mechanisms Behind Pustular Lesions And Pigmentation
Published on: November 23, 2025
Pathophysiology of Transient Neonatal Pustular Melanosis Mechanisms behind pustular lesions and pigmentation featured image

This article aims to help you, as the reader, understand the information and expand your knowledge on this topic and other subtopics related to this question.

Introduction 

Transient Neonatal Pustular Melanosis (TNPM) is a moderate skin condition that mostly affects newborn babies. This is a condition that appears as small pus-filled bumps that leave dark spots on the skin surface and then fade away without any treatment. African American babies typically experience TNPM more than other races, as it occurs in 4.4% of cases compared to 0.6% of caucasian newborn babies.1 

Doctors are trying to understand how the bumps develop and how the immune system responds in newborn babies.

TNPM comes from complex immune and inflammatory conditions, which can lead to pustular (pus-filled) lesions that cause hyperpigmentation. This condition is caused by a mix of inflammation and melanocytes, which produce melanin for the skin's pigment, and over time heals without a scar because there is no deep cut into the skin's surface barrier.

Epidemiology and clinical features 

TNPM is a benign skin condition that is primarily found amongst newborns and within African American children, and a lower incidence in Asian and Caucasian infants. In the beginning days of a newborn's life, TNPM can be seen as non-inflamed pustules which are surrounded by a red halo, and when they rupture, they leave behind pigmented macules that can last for weeks.2 The pigmented macules may darken gradually over time or remain on the skin for a long time. These scars can be present on the face, limbs and chest. 

Overall, TNPM does not require any strong medications or treatment to heal because it heals by itself over time. However, there are treatments, such as ointments, to quicken the process of healing of the dark scarring.3

Clinical presentation and diagnosis

Diagnosis is based on the appearance and characteristics of the progression on the skin. There are different symptoms that can be found during diagnosis to distinguish which type of TNPM is present.

  • Milia: Small, white keratin-filled cysts that have no inflammation
  • Neonatal acne:  Inflammatory papules that develop during the very first weeks of the condition

Pathophysiology of pustular lesions 

The pathophysiology of pustular lesions in TNPM is triggered by inflammation in the skin due to a minor irritation. This causes an infiltration of immune cells, specifically neutrophils, in the superficial dermis layer of the skin. After inflammation, pustules form, and the neutrophils are usually the first immune response that causes a rupture of the superficial epidermis layers. 

Intracellular fluid accumulation is present due to inflammatory mediators, which damage the keratinocytes (keratin-producing cells) in the epidermis.4  Furthermore, when the neutrophils arrive at the infection site, they move into the subcorneal layer of the epidermis, which releases proteolytic enzymes like elastase. These neutrophils break down intercellular junctions that cause the small gaps to form within the epidermis layer and lead to microvesicles. Microvesicles merge into bigger pustules that are composed of plasma proteins, neutrophils and sterile debris. Histamine is part of the fluid within the pustules, which leaks into the extracellular space. The pigmentation that is seen afterwards is because of excess melanosome transfer from melanocytes.5   

Resolution of lesions

  • Healing through re-epithelialisation (where the skin regenerates over a wound)
  • Residual pigmentation formulates post-inflammatory hyperpigmentation (macules)
  • Takes 24 - 48 hours for pustules to decrease in volume
  • No scarring or permanent damage

Re-epithelialisation happens underneath the skin, so the new keratinocytes move to cover the empty area and heal without any medication or treatment. For babies, gentle and simple skincare products such as moisturisers are recommended because of their sensitive skin to prevent drying or cracking of the skin. When the babies turn five days of age, the pustules disappear. 

Infections can appear, so this would require topical treatments to support the healing process. However, there is no specific therapy required for TNPM, and this disease is not associated with baby mortality or morbidity rates.6

Pigmentation mechanism

Melanocytes are specialised cells in the epidermis that produce skin pigmentation or melanin. Melanin synthesis and transfer to keratinocytes cause the pigmentation and post-inflammatory hyperpigmentation, and are found usually in dark skinned communities. 

When the skin has inflammation like eczema, it can use inflammatory chemicals and enzymes, such as tyrosinase, to produce melanocytes. Then the melanocytes migrate to areas in close proximity to cause the appearance of darker patches on the skin and produce excess pigment. 

Post-inflammatory hyperpigmentation (PIH) is the trigger of overproduction of melanin:

  • Epidermal PIH: Causes brown discolouration on the top layer of the skin because of the excess melanin
  • Dermal PIH: Causes a blue-grey discolouration which lasts longer than epidermal PIH because it’s on the layer under the top layer of skin7

Interleukin-6 (IL-6) is an example of an inflammatory chemical that causes pigmentation, and so individuals with darker skin tones are usually more prone to PIH. Darker skin tones have more pigmentation because they produce melanin naturally more than lighter skin tones. This is why in babies it is more noticeable and long-lasting. In the basal layer of the epidermis, the epidermal PIH has a strong amount of melanin. Basically, the overstimulation of melanocytes triggers residual pigmentation. The depth of how deep the pigment is within the layers of skin will determine how long it will take to fade the discolouration.8

Clinical implications and diagnosis

Diagnosing TNPM involves differentiating between the several variations of infectious pustular diseases. In clinics, they are represented as red pustules that are dispersed across the chin, neck and back of the newborn babies. 

Wright or Giemsa stains analyse the pustules by finding the specific bacteria present, which is important to rule out systemic infections.9 Healthcare providers will reassure the parents of the baby that the skin condition is non-threatening, so they don’t have any serious concerns or panic. The parents will be advised not to use any medical interventions that aren't prescribed by a healthcare professional. After three months, the residual pigmentation should heal gradually within due time, but in other cases, it can take longer.10

Conclusion 

Overall, TNPM is a benign skin disorder that only affects newborn babies. It is characterised as small pustules that can leave transient hyperpigmented macules(dark spots). Pustular lesions are simply small raised bumps on the skin that have pus and are caused by an inflammatory response, but eventually disappear in time without any further skin irritation; hyperpigmentation may remain for a few weeks in some cases. TNPM must be properly diagnosed to avoid any use of abrasive treatments, which could worsen the skin barrier of a newborn. As there is no microbial involvement and no infections, no medical intervention is required. 

Ethnic and genetic factors play a significant role in this skin condition because it is more common in African American infants. However, newborn babies with lighter skin tones can also experience this skin condition, but it is less common. 

TNPM is still being analysed and studied to understand the various factors and causes of this skin condition. Therefore, when neonatology is more comprehensively understood, it helps to differentiate between serious neonatal pustular disorders like bacterial infections and TNPM. 

Summary 

TNPM is a benign neonatal condition that occurs in newborn babies, usually darker skinned infants. The pustular lesions are produced from an inflammatory response because of the melanocyte activation. Future research aims to focus on the role of maternal hormones and immune response to improve accurate diagnosis. Many resolutions are being developed to improve treatment for TNPM that is gentle on the skin. Genetic influence is also an important factor in whether the baby carries the trait for the skin condition. However, the exact root of the TNPM is still being researched.

References

  1. McMahon P, Goddard D, Frieden IJ. Pediatric dermatology inpatient consultations: A retrospective study of 427 cases. Journal of the American Academy of Dermatology [Internet]. 2013 [cited 2025 Mar 20]; 68(6):926–31. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0190962212022827.
  2. Chia PS, Leung C, Hsu YL, Lo CY. An infant with transient neonatal pustular melanosis presenting as pustules. Pediatrics & Neonatology [Internet]. 2010 Dec 1;51(6):356–8. Available from: https://doi.org/10.1016/s1875-9572(10)60069-1
  3. Boffa MM, Borg J, Grech M, Pace D, Montalto SA. Transient neonatal pustular melanosis: An unusual and challenging eruption. Clinical Case Reports [Internet]. 2023 Oct 25;11(11). Available from: https://doi.org/10.1002/ccr3.8092
  4. Agusti-Mejias A, Messeguer F, Febrer I, Alegre V. Transient neonatal pustular melanosis. Actas Dermo-Sifiliográficas [Internet]. 2012 Dec 29;104(1):84–5. Available from: https://doi.org/10.1016/j.adengl.2012.11.012
  5. Eichenfield LF, Frieden IJ. Neonatal and infant dermatology [Internet]. 2014. Available from: https://openlibrary.org/books/OL28538900M/Neonatal_and_Infant_Dermatology
  6. Kutlubay Z, Tanakol A, Engýn B, Onel C, Sýmsek E, Serdaroglu S, et al. Newborn skin: Common skin problems. PubMed [Internet]. 2017 Jan 1;12(1):42–7. Available from: https://pubmed.ncbi.nlm.nih.gov/28878836
  7. Fu C, Chen J, Lu J, Yi L, Tong X, Kang L, et al. Roles of inflammation factors in melanogenesis (Review). Molecular Medicine Reports [Internet]. 2020 Jan 17; Available from: https://doi.org/10.3892/mmr.2020.10950
  8. Videira IFDS, Moura DFL, Magina S. Mechanisms regulating melanogenesis*. Anais Brasileiros De Dermatologia [Internet]. 2013 Feb 1;88(1):76–83. Available from: https://doi.org/10.1590/s0365-05962013000100009
  9. Ghosh S. Neonatal pustular dermatosis: an overview. DOAJ (DOAJ: Directory of Open Access Journals) [Internet]. 2015 Mar 31;60(2):211. Available from: https://doaj.org/article/175a8f9345ee4abc8dc360363049fed3
  10. Boffa MM, Borg J, Grech M, Pace D, Montalto SA. Transient neonatal pustular melanosis: An unusual and challenging eruption. Clinical Case Reports [Internet]. 2023 Oct 25;11(11). Available from: https://doi.org/10.1002/ccr3.8092
Share

Anne Koutouan

Bachelor of Science in Biomedical Science

arrow-right